07/09/2026
Quality isn't just a department. It's a discipline — and the numbers show it.
This year, two Velocity sites — Berlin, Germany and Savannah, GA — underwent FDA inspections, both closing with zero Form 483 observations. For context, FDA's own published data shows roughly one in four clinical investigator inspections results in a 483 being issued. Two clean inspections isn't luck. It's the output of a system.
That system runs across three dedicated teams. Quality Assurance manages controlled documents, leads internal and regulatory inspections, supports sponsor audits, and drives CAPA. Quality Systems administers our QMS, oversees company-wide training compliance, and validates new systems and processes. Quality Control applies a risk-based approach to targeted review of trial data — consent, eligibility, visit compliance, safety reporting, and source verification.
Since 2022, we've completed 156 sponsor audits — 25 in the first half of 2026 alone — plus 29 regulatory inspections. Every one is an opportunity for a sponsor or regulator to look under the hood. We welcome that scrutiny, because we build for it every day.
Findings are the industry norm. A clean record is a choice — and it takes a dedicated team of experts to make it consistently.
That's the team behind Velocity.